Momelotinib: a promising drug for patients with myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:43 2 years ago 758 Скачать Далее
The promise of momelotinib in the treatment of myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:00 1 year ago 479 Скачать Далее
MOMENTUM & the potential impact of approval of momelotinib in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 2:20 1 year ago 500 Скачать Далее
Assessing the impact of momelotinib on transfusion burden in MF: analysis of SIMPLIFY-1 & MOMENTUM VJHemOnc – Video Journal of Hematology & HemOnc 2:26 4 months ago 72 Скачать Далее
Latest updates on momelotinib: safety, durability of response & survival benefit VJHemOnc – Video Journal of Hematology & HemOnc 3:02 1 year ago 380 Скачать Далее
Momelotinib vs. ruxolitinib in myelofibrosis patients with thrombocytopenia VJHemOnc – Video Journal of Hematology & HemOnc 1:42 3 years ago 410 Скачать Далее
Updates on the use of momelotinib for the treatment of MF & clinical trials evaluating this agent VJHemOnc – Video Journal of Hematology & HemOnc 1:26 1 year ago 496 Скачать Далее
An insight into the MOMENTUM trial: safety and efficacy of momelotinib for the treatment of MF VJHemOnc – Video Journal of Hematology & HemOnc 3:03 2 years ago 342 Скачать Далее
Recent updates from the MOMENTUM trial and the value of momelotinib for the treatment of MF VJHemOnc – Video Journal of Hematology & HemOnc 1:53 1 year ago 114 Скачать Далее
The recent FDA approval of momelotinib in MF & implications for clinical practice VJHemOnc – Video Journal of Hematology & HemOnc 2:00 8 months ago 186 Скачать Далее
Efficacy of momelotinib in thrombocytopenic patients with myelofibrosis from MOMENTUM VJHemOnc – Video Journal of Hematology & HemOnc 3:48 2 years ago 294 Скачать Далее
Ruxolitinib, pacritinib, fedratinib or momelotinib for thrombocytopenic patients with myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:05 2 years ago 582 Скачать Далее
MOMENTUM: momelotinib vs danazol in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:12 3 years ago 837 Скачать Далее
Analysis of long-term exposure to momelotinib in the Phase III SIMPLFY myelofibrosis trials VJHemOnc – Video Journal of Hematology & HemOnc 2:07 3 years ago 109 Скачать Далее
Long-term safety of momelotinib for myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 2:16 4 years ago 101 Скачать Далее
FDA Approves JAK Inhibitor Momelotinib for Myelofibrosis in Anemic Adults Medical Dialogues 2:25 9 months ago 208 Скачать Далее
Momelotinib for the treatment of myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:40 4 years ago 197 Скачать Далее
Momelotinib vs SoC in patients with MF and anemia: an analysis from the SIMPLIFY-2 trial VJHemOnc – Video Journal of Hematology & HemOnc 1:45 7 months ago 140 Скачать Далее
Update on momelotinib for myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 4:25 3 years ago 198 Скачать Далее
Quantifying the anemia benefit of momelotinib in MF: analysis of data from SIMPLIFY-1 & SIMPLIFY-2 VJHemOnc – Video Journal of Hematology & HemOnc 2:20 4 months ago 61 Скачать Далее